EHA 2018 prof. dr. S. Verstovsek

Prof. dr. Srdan Verstovsek, MD Anderson Houston (US)

 

SAFETY AND EFFICACY OF RUXOLITINIB IN PATIENTS WITH DIPSS INTERMEDIATE-1–RISK MYELOFIBROSIS (MF) FROM JUMP: AN OPEN-LABEL, MULTICENTER, SINGLE-ARM, EXPANDED-ACCESS STUDY

 

 

Bekijk het abstract

 

Click here for the prescribing information of Jakavi
 

0419HEM1151436
×

Ask Speakers

×

Medical Information Request